A global distribution of biopharmaceutical companies by Research & Development spend.
Where does innovation originate?
The 2020 edition of the European Union Industrial R&D Investment Scoreboard comprises of 2,500 private-sector companies investing the largest sums in research and development in the world. These companies invested a total of €904.2 billion in 2019. The amount of R&D investment by these companies is equivalent to more than 60% of the total expenditure on R&D worldwide, and to around 90% of the R&D expenditure financed by the business sector worldwide.
The scoreboard database includes 431 biopharmaceuticals manufacturers across 25 countries, contributing a total of €166 billion in research and development – 18% of the global estimate. The drug industry is the one of the most research-intensive in the world.
The United States is the largest contributor to research and development by far, accounting for 49% of the total global biopharmaceutical R&D spend.
The reference period for the 2020 Scoreboard is the year 2019, thus the effects of the COVID-19 pandemic are not yet reflected in the dataset.
Here is the complete geographic spread of biopharmaceutical investors in the world.